Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Stintzing

Showing results (121-130 of 206) with videos related to

Pageof 21
Sort By:
Minerva Medica|September 12, 2017
Multidisciplinary treatment of colorectal liver metastasesTobias S Schiergens, Jobst von Einem, Michael N Thomas, et al.
International Journal of Cancer|December 23, 2014
NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumorsChristoph Schulz, Frank Kullmann, Volker Kunzmann, et al.
Scientific Reports|June 10, 2021
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patientsMadiha Naseem, Shu Cao, Dongyun Yang, et al.
Anti-Cancer Drugs|July 9, 2020
Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) studyChristoph Schulz, Volker Heinemann, Kathrin Heinrich, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2024
A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidednessTakayuki Yoshino, Naushin Hooda, Diana Younan, et al.
International Journal of Molecular Sciences|March 27, 2025
Genetic Polymorphisms in MHC Classes I and II Predict Outcomes in Metastatic Colorectal CancerPooja Mittal, Francesca Battaglin, Yan Yang, et al.
Cancers|February 25, 2022
Prognostic and Predictive Molecular Markers in CholangiocarcinomaSandra Pavicevic, Sophie Reichelt, Deniz Uluk, et al.
Pharmacogenetics and Genomics|September 10, 2014
Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer patients after surgery with curative intentTakeru Wakatsuki, Sebastian Stintzing, Wu Zhang, et al.
Molecular Cancer Therapeutics|March 31, 2021
RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICCHiroyuki Arai, Shu Cao, Francesca Battaglin, et al.
Pharmacogenetics and Genomics|September 10, 2014
Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patientsYu Sunakawa, Takeru Wakatsuki, Dongyun Yang, et al.
Pageof 21

Showing results (121-130 of 206) with videos related to

Sort By:
Pageof 21
Minerva Medica|September 12, 2017
Multidisciplinary treatment of colorectal liver metastasesTobias S Schiergens, Jobst von Einem, Michael N Thomas, et al.
International Journal of Cancer|December 23, 2014
NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumorsChristoph Schulz, Frank Kullmann, Volker Kunzmann, et al.
Scientific Reports|June 10, 2021
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patientsMadiha Naseem, Shu Cao, Dongyun Yang, et al.
Anti-Cancer Drugs|July 9, 2020
Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) studyChristoph Schulz, Volker Heinemann, Kathrin Heinrich, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2024
A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidednessTakayuki Yoshino, Naushin Hooda, Diana Younan, et al.
International Journal of Molecular Sciences|March 27, 2025
Genetic Polymorphisms in MHC Classes I and II Predict Outcomes in Metastatic Colorectal CancerPooja Mittal, Francesca Battaglin, Yan Yang, et al.
Cancers|February 25, 2022
Prognostic and Predictive Molecular Markers in CholangiocarcinomaSandra Pavicevic, Sophie Reichelt, Deniz Uluk, et al.
Pharmacogenetics and Genomics|September 10, 2014
Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer patients after surgery with curative intentTakeru Wakatsuki, Sebastian Stintzing, Wu Zhang, et al.
Molecular Cancer Therapeutics|March 31, 2021
RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICCHiroyuki Arai, Shu Cao, Francesca Battaglin, et al.
Pharmacogenetics and Genomics|September 10, 2014
Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patientsYu Sunakawa, Takeru Wakatsuki, Dongyun Yang, et al.
Pageof 21